MarkR.FaheyMD

PubMed

• Quality of anesthesia practice.
  Mark R. Fahey> ;Anesthesiology. 2004 Aug 1
• Pharmacokinetics and pharmacodynamics of atracurium in the elderly.
  Kitts JB, Fisher DM, Canfell PC, Spellman MJ, Caldwell JE, Heier T, Fahey MR, Miller RD> ;Anesthesiology. 1990-02-01
• Cerebrospinal fluid concentrations of laudanosine after administration of atracurium.
  Fahey MR, Canfell PC, Taboada T, Hosobuchi Y, Miller RD> ;Br J Anaesth. 1990-01-01
• Modification of central nervous system effects of laudanosine by inhalation anaesthetics.
  Shi WZ, Fahey MR, Fisher DM, Miller RD> ;Br J Anaesth. 1989-11-01
• Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia.
  Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD> ;Br J Anaesth. 1989-10-01
• Atracurium, vecuronium, and pancuronium do not alter the minimum alveolar concentration of halothane in humans.
  Fahey MR, Sessler DI, Cannon JE, Brady K, Stoen R, Miller RD> ;Anesthesiology. 1989-07-01
• The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.
  Caldwell JE, Canfell PC, Castagnoli KP, Lynam DP, Fahey MR, Fisher DM, Miller RD> ;Anesthesiology. 1989-01-01
• The dose-response relationship of mivacurium chloride in humans during nitrous oxide-fentanyl or nitrous oxide-enflurane anesthesia.
  Caldwell JE, Kitts JB, Heier T, Fahey MR, Lynam DP, Miller RD> ;Anesthesiology. 1989-01-01
• Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.
  Caldwell JE, Castagnoli KP, Canfell PC, Fahey MR, Lynam DP, Fisher DM, Miller RD> ;Br J Anaesth. 1988-12-01
• Large doses of vecuronium and plasma histamine concentrations.
  Cannon JE, Fahey MR, Moss J, Miller RD> ;Can J Anaesth. 1988-07-01
• Vecuronium inhibits histamine N-methyltransferase.
  Futo J, Kupferberg JP, Moss J, Fahey MR, Cannon JE, Miller RD> ;Anesthesiology. 1988-07-01
• Continuous infusion of vecuronium: the effect of anesthetic agents.
  Cannon JE, Fahey MR, Castagnoli KP, Furuta T, Canfell PC, Sharma M, Miller RD> ;Anesthesiology. 1987-10-01
• Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination.
  Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD> ;Anesthesiology. 1986-07-01
• Pharmacology of laudanosine in dogs.
  Hennis PJ, Fahey MR, Canfell PC, Shi WZ, Miller RD> ;Anesthesiology. 1986-07-01
• The metabolic disposition of laudanosine in dog, rabbit, and man.
  Canfell PC, Castagnoli N, Fahey MR, Hennis PJ, Miller RD> ;Drug Metab. Dispos.. 1986-01-01
• Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits.
  Shi WZ, Fahey MR, Fisher DM, Miller RD, Canfell C, Eger EI> ;Anesthesiology. 1985-12-01
• Effect of renal failure on laudanosine excretion in man.
  Fahey MR, Rupp SM, Canfell C, Fisher DM, Miller RD, Sharma M, Castagnoli K, Hennis PJ> ;Br J Anaesth. 1985-11-01
• The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
  Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ> ;Anesthesiology. 1984-12-01
• Clinical pharmacology of vecuronium and atracurium.
  Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ> ;Anesthesiology. 1984-10-01
• Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
  Rupp SM, Fahey MR, Miller RD> ;Br J Anaesth. 1983-01-01
• New muscle relaxants.
  Fahey MR, Miller RD> ;Contemp Anesth Pract. 1983-01-01
• Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques.
  Fisher DM, Fahey MR, Cronnelly R, Miller RD> ;Anesthesiology. 1982-10-01
• Pharmacokinetics of edrophonium in anephric and renal transplant patients.
  Morris RB, Cronnelly R, Miller RD, Stanski DR, Fahey MR> ;Br J Anaesth. 1981-12-01
• Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
  Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA> ;Br J Anaesth. 1981-10-01
• Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
  Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P> ;Anesthesiology. 1981-07-01
• Join now to see all